Fariborz Kamal's most recent trade in 4D Molecular Therapeutics Inc was a trade of 178,400 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 6, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| 4D Molecular Therapeutics Inc | Fariborz Kamal | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 178,400 | 178,400 | - | - | Stock Option (Right to Buy) |